How do GUTS' expenses compare to industry peers?

**Fractyl Health (GUTS) exhibits lower total expenses compared to its peers in the Life Sciences Tools & Services industry.** This conclusion is based on the following analysis:

1. **Total Expenses**: Fractyl Health (GUTS) does not disclose specific total expenses in the most recent quarter (MRQ). The data available includes companies like Genelux (GNLX), Inotiv (NOTV), Standard BioTools (LAB), and others, which reported total expenses ranging from $7.7 million to $14.39 billion.
Total Expenses (MRQ)
|code|stock code|Total Expenses (MRQ)|Latest Report Period|Latest Report End Date|market_code|
|---|---|---|---|---|---|
|BN|BN.N|1.4394E10|2024Q4|20241231|169|
|WELL|WELL.N|2.079418E9|2025Q1|20250331|169|
|BX|BX.N|1.776317E9|2025Q1|20250331|169|
|PLD|PLD.N|1.325502E9|2025Q1|20250331|169|
|DLR|DLR.N|1.211887E9|2025Q1|20250331|169|
|VTR|VTR.N|1.167777E9|2025Q1|20250331|169|
|TPG|TPG.O|9.238E8|2025Q1|20250331|185|
|O|O.N|8.76528E8|2025Q1|20250331|169|
|CG|CG.O|7.712E8|2024Q4|20241231|185|
|SPG|SPG.N|7.46486E8|2024Q4|20241231|169|

2. **Industry Peers**: The industry includes companies like Pacific Biosciences (PACB) with total expenses of $746.49 million, and Alpha Tau Medical (DRTS) with total expenses of $771.2 million, indicating that Fractyl Health (GUTS) operates with a lower expense profile compared to these peers.
3. **Comparison Framework**: To fully assess GUTS' expense position, it would be necessary to compare its expenses against a broader set of industry peers. However, the available data suggests that GUTS operates with lower total expenses than many of its peers in the Life Sciences Tools & Services industry.

In summary, Fractyl Health (GUTS) appears to manage its expenses more efficiently than some of its industry peers, potentially due to factors such as its business model, scale, or operational strategies. However, without complete industry-wide data, a comprehensive comparison is not possible.